Nouvelle déclaration d'incident
No de la demande: 2019-2006
Numéro de référence du titulaire d'homologation: 2372262
Nom du titulaire (nom légal complet, aucune abbréviation): Bell Laboratories, Inc.
Adresse: 3699 Kinsman Blvd
Ville: Madison
État: WI
Pays: USA
Code postal /Zip: 53704
Incident chez un animal domestique
Pays: UNITED STATES
État: ARKANSAS
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 12455-132-3240
Nom du produit: Tomcat with Bromethalin Bait Chunx
Appât
Non
Inconnu
Inconnu
Professionnel de la santé
Dog / Chien
Labrador Retriever
1
Homme
3
70.00
lbs
Orale
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Oui
Inconnu
Unknown/Inconnu
Accidental ingestion/Ingestion accident.
(p.ex. description des symptômes tels que la fréquence et la gravité
1/10/2019 8:41:29 AM A veterinarian reported that two dogs may have ingested up to 2 pounds of product from a 4 pound bucket of Tomcat with Bromethalin Bait Chunx approximately 4 days prior. One dog already died due to anemia and pulmonary congestion. It was not specified when the dog died or if any treatments were performed. The second dog was currently in the clinic with bleeding from the nose, respiratory distress, dilated pupils, occasional nystagmus, decreased pupilary light response. and generalized weakness. The dog was anemic but did not bleed excessively from the venipuncture site and did not have any bruising present. The veterinarian stated the pet owner did not think the dogs could have gotten into any other type of rodenticide product. The veterinarian was seeking treatment recommendations. The dog did reportedly live outdoors. Typical clinical signs for bromethalin were discussed along with symptomatic and supportive care recommendations based on the dog's clinical signs. No further information was received in this case.
Majeure
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.
Professionnel de la santé
Dog / Chien
Unknown
1
Inconnu
Inconnu
Inconnu
Orale
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Inconnu
Inconnu
Inconnu
Mort
Accidental ingestion/Ingestion accident.
(p.ex. description des symptômes tels que la fréquence et la gravité
1/10/2019 8:41:29 AM A veterinarian reported that two dogs may have ingested up to 2 pounds of product from a 4 pound bucket of Tomcat with Bromethalin Bait Chunx approximately 4 days prior. One dog already died due to anemia and pulmonary congestion. It was not specified when the dog died or if any treatments were performed. The second dog was currently in the clinic with bleeding from the nose, respiratory distress, dilated pupils, occasional nystagmus, decreased pupilary light response. and generalized weakness. The dog was anemic but did not bleed excessively from the venipuncture site and did not have any bruising present. The veterinarian stated the pet owner did not think the dogs could have gotten into any other type of rodenticide product. The veterinarian was seeking treatment recommendations. The dog did reportedly live outdoors. Typical clinical signs for bromethalin were discussed along with symptomatic and supportive care recommendations based on the dog's clinical signs. No further information was received in this case.
Mort
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.